Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kathrine S Rallis

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Cancer Diagnosis & Prognosis|November 3, 2025
Renal Epithelioid Angiomyolipomas: Clinicopathological Features, Diagnosis, and ManagementKathrine S Rallis
Expert Review of Anticancer Therapy|December 24, 2025
Targeting angiogenesis in cancer therapy: lessons learned and paths forwardKathrine S Rallis
Cureus|January 4, 2021
Advances in Epigenetic Cancer TherapeuticsChristopher Hillyar, Kathrine S Rallis, Jajini Varghese
Anticancer Research|January 9, 2021
Chemoradiotherapy in Cancer Treatment: Rationale and Clinical ApplicationsKathrine S Rallis, Thomas Ho Lai Yau, Michail Sideris
Cancer Diagnosis & Prognosis|January 4, 2024
Assessing Radiological Response to Immunotherapy in Lung Cancer: An Evolving ArenaKathrine S Rallis, Shania Makker, Aruni Ghose, et al.
Blood|May 7, 2026
Bone Marrow Stem Cell Connexins: Misconceptions and New InsightsAbhishek K Singh, Kathrine S Rallis, Jose A Cancelas
World Journal of Clinical Oncology|August 11, 2022
Immunotherapy for advanced hepatocellular carcinoma: From clinical trials to real-world data and future advancesKathrine S Rallis, Dimitrios Makrakis, Ioannis A Ziogas, et al.
Anticancer Research|March 31, 2021
T-cell-based Immunotherapies for Haematological Cancers, Part A: A SWOT Analysis of Immune Checkpoint Inhibitors (ICIs) and Bispecific T-Cell Engagers (BiTEs)Kathrine S Rallis, Christopher R T Hillyar, Michail Sideris, et al.
Epigenomics|May 16, 2022
Complex cross-talk between EZH2 and miRNAs confers hallmark characteristics and shapes the tumor microenvironmentChristopher Rt Hillyar, Shivani S Kanabar, Kathrine S Rallis, et al.
Anticancer Research|March 31, 2021
T-cell-based Immunotherapies for Haematological Cancers, Part B: A SWOT Analysis of Adoptive Cell TherapiesKathrine S Rallis, Christopher R T Hillyar, Michail Sideris, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Cancer Diagnosis & Prognosis|November 3, 2025
Renal Epithelioid Angiomyolipomas: Clinicopathological Features, Diagnosis, and ManagementKathrine S Rallis
Expert Review of Anticancer Therapy|December 24, 2025
Targeting angiogenesis in cancer therapy: lessons learned and paths forwardKathrine S Rallis
Cureus|January 4, 2021
Advances in Epigenetic Cancer TherapeuticsChristopher Hillyar, Kathrine S Rallis, Jajini Varghese
Anticancer Research|January 9, 2021
Chemoradiotherapy in Cancer Treatment: Rationale and Clinical ApplicationsKathrine S Rallis, Thomas Ho Lai Yau, Michail Sideris
Cancer Diagnosis & Prognosis|January 4, 2024
Assessing Radiological Response to Immunotherapy in Lung Cancer: An Evolving ArenaKathrine S Rallis, Shania Makker, Aruni Ghose, et al.
Blood|May 7, 2026
Bone Marrow Stem Cell Connexins: Misconceptions and New InsightsAbhishek K Singh, Kathrine S Rallis, Jose A Cancelas
World Journal of Clinical Oncology|August 11, 2022
Immunotherapy for advanced hepatocellular carcinoma: From clinical trials to real-world data and future advancesKathrine S Rallis, Dimitrios Makrakis, Ioannis A Ziogas, et al.
Anticancer Research|March 31, 2021
T-cell-based Immunotherapies for Haematological Cancers, Part A: A SWOT Analysis of Immune Checkpoint Inhibitors (ICIs) and Bispecific T-Cell Engagers (BiTEs)Kathrine S Rallis, Christopher R T Hillyar, Michail Sideris, et al.
Epigenomics|May 16, 2022
Complex cross-talk between EZH2 and miRNAs confers hallmark characteristics and shapes the tumor microenvironmentChristopher Rt Hillyar, Shivani S Kanabar, Kathrine S Rallis, et al.
Anticancer Research|March 31, 2021
T-cell-based Immunotherapies for Haematological Cancers, Part B: A SWOT Analysis of Adoptive Cell TherapiesKathrine S Rallis, Christopher R T Hillyar, Michail Sideris, et al.
Pageof 3